Kim Kelderman
Net Worth

Last updated:

What is Kim Kelderman net worth?

The estimated net worth of Mr. Kim Kelderman is at least $9,767,456 as of 24 Aug 2023. He owns shares worth $21,920 as insider, has earned $1,045,536 from insider trading and has received compensation worth at least $8,700,000 in Bio-Techne Corporation.

What is the salary of Kim Kelderman?

Mr. Kim Kelderman salary is $1,450,000 per year as Pres of Diagnostics & Genomics in Bio-Techne Corporation.

How old is Kim Kelderman?

Mr. Kim Kelderman is 58 years old, born in 1967.

What stocks does Kim Kelderman currently own?

As insider, Mr. Kim Kelderman owns shares in one company:

Company Title Shares Price per share Total value
Bio-Techne Corporation (TECH) Pres of Diagnostics & Genomics 400 $54.8 $21,920

What does Bio-Techne Corporation do?

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

TECH logo
TECH
Bio-Techne Corporation
$54.8

Kim Kelderman insider trading

Bio-Techne Corporation

Mr. Kim Kelderman has made 5 insider trades between 2019-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 8,060 units of TECH stock on 5 Aug 2023. As of 24 Aug 2023 he still owns at least 400 units of TECH stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (Right to Buy) 2,100 $47.6 $99,960
Option
Common Stock 2,100 $47.6 $99,960
Option
Restricted Stock Units 8,060 N/A N/A
Option
Common Stock 8,060 N/A N/A
Option
Stock Option (Right to Buy) 663 $150.78 $99,967
Option
Common Stock 663 $150.78 $99,967
Option
Restricted Stock Units 2,363 N/A N/A
Option
Common Stock 2,363 N/A N/A
Option
Stock Option (Right to Buy) 1,989 $150.78 $299,901
Option
Common Stock 1,989 $150.78 $299,901
Option
Stock Option (Right to Buy) 500 $150.78 $75,390
Option
Common Stock 500 $150.78 $75,390
Sale
Common Stock 500 $504.77 $252,386
Sale
Common Stock 822 $529.04 $434,871
Option
Common Stock 1,691 $150.78 $254,969
Option
Restricted Stock Units 1,691 $150.78 $254,969
Sale
Common Stock 811 N/A N/A
Sale
Common Stock 845 $424 $358,280
Option
Common Stock 1,667 $150.78 $251,350
Option
Restricted Stock Units 1,667 $150.78 $251,350
Sale
Common Stock 823 N/A N/A
Option
Common Stock 1,666 N/A N/A
Option
Restricted Stock Units 1,666 N/A N/A
Option
Common Stock 1,667 N/A N/A
Option
Restricted Stock 1,667 N/A N/A

Bio-Techne key executives

Bio-Techne Corporation executives and other stock owners filed with the SEC: